Page 8 - Pharma Stocks
Emcure Pharmaceuticals share gains on foraying into daily supplements space
The uptick in the Emcure Pharmaceuticals share price came after the company announced its entry into the daily supplements space with the expansion of its Arth range
 "Emcure Pharmaceuticals share gains on foraying into daily supplements space")
Stocks to Watch: Adani Enterprises, Zomato, Swiggy, Cement, Pharma stocks
Stock market today: Pan-Indian average cement prices have risen for three consecutive months. In February, prices increased by ₹3 per 50 kg bag (up 1% M-o-M and 2% Y-o-Y) to ₹374 per bag
 "Stocks to Watch: Adani Enterprises, Zomato, Swiggy, Cement, Pharma stocks")
Defensive sector weightage in Nifty 50 declines to 15 year low
Underperforms in falling market for first time in over 20 years
 "Defensive sector weightage in Nifty 50 declines to 15 year low")
Biocon share price up 2% as arm launches Yesintek in US; check details here
Biocon share rose after Biocon Biologics, a subsidiary of Biocon, announced that Yesintek (ustekinumab-kfce) is now available to patients in US
 "Biocon share price up 2% as arm launches Yesintek in US; check details here")
Zydus Lifesciences, Granules, Glenmark: Nifty Pharma up despite weak market
Nifty Pharma among others has gained 0.8 per cent in trade, logging an intra-day high at 20,550.6
 "Zydus Lifesciences, Granules, Glenmark: Nifty Pharma up despite weak market")
Suven Pharma soars 14% on heavy volumes; surges 43% from January low
Suven Pharma is set to benefit from high-growth cutting-edge CDMO segments and its proven track record to drive traditional business.
 "Suven Pharma soars 14% on heavy volumes; surges 43% from January low")
Nifty Pharma tanks 3% on Trump's tariff threat; Zydus, Lupin down upto 10%
The decline in pharma stocks followed comments from President Donald Trump, who indicated that the US may impose tariffs of around 25 per cent on pharmaceutical, automobile, and semiconductor imports
 "Nifty Pharma tanks 3% on Trump's tariff threat; Zydus, Lupin down upto 10%")
Suven Pharma, Divis, Syngene: Why Macquarie is betting big on Indian pharma
Pharma stocks list: Divis Labs share price rallied 1.9% intraday, Suven Pharma share price surged 4.6%, Blue Jet Healthcare share price added 4.9%, and Syngene International share price rose 1.5%
 "Suven Pharma, Divis, Syngene: Why Macquarie is betting big on Indian pharma")
Pharma stocks plunge amid tariff concerns, but analysts see limited impact
Pharma stocks fell on Friday on concerns of tariff on imports
 "Pharma stocks plunge amid tariff concerns, but analysts see limited impact")
Nifty Pharma index slips 3%; Natco, Glenmark, Lupin, Laurus down up to 10%
Thus far in the calendar year 2025, the Nifty Pharma index has slipped 11 per cent, as against 3.7 per cent fall in Nifty 50.
 "Nifty Pharma index slips 3%; Natco, Glenmark, Lupin, Laurus down up to 10%")
PI Industries hits 52-week low; down 11% in one week on poor Q3 earnings
PI Industries' steady Q3FY25 performance, cautious near-term outlook, and portfolio challenges are likely to affect the business dynamics in FY26 and FY27, according to analysts.
 "PI Industries hits 52-week low; down 11% in one week on poor Q3 earnings")
FDC hits 52-week low, stock slips 9% on weak Q3 results
EBITDA for Q3FY25 was impacted by lower sales in export formulation biz, price reduction in the Electral range of products, driven by NLEM price revisions changes in the product mix, and higher cost.
 "FDC hits 52-week low, stock slips 9% on weak Q3 results")
Analysts bullish on Lupin after Q3; share pops 6%; Goldman Sachs ups target
Domestic, as well as global brokerages are optimistic about Lupin's future, citing strong earnings visibility and a promising product pipeline
 "Analysts bullish on Lupin after Q3; share pops 6%; Goldman Sachs ups target")
Alkem Labs, Ipca, Divi's: Three reasons why pharma stocks are falling today
Stocks such as Natco, Dr. Reddy's, Cipla, Mankind, Torrent, Sun Pharma, Abbott, and Glenmark slipped in the range of 1-2 per cent
 "Alkem Labs, Ipca, Divi's: Three reasons why pharma stocks are falling today")
Zydus Life up 3% on mixed Q3, mcap tops Rs 1 trn; analysts split on outlook
Despite challenges from a lower-margin product mix, Zydus Life benefitted from forex gains and a favourable tax rate, which led to a PAT beat, analysts said
Ami Organics extends rally on strong Q3 results; stock zooms 30% in 4 days
The management believes, that on account of ramp-up of existing products, Fermion contract, and potential commercialisation of another CDMO contract in FY26E, Ami has strong revenue visibility.
 "Ami Organics extends rally on strong Q3 results; stock zooms 30% in 4 days")
Senores Pharmaceuticals races 17% on robust Q3; profit more than doubles
The rise in Senores Pharmaceuticals share came after the company's strong show in the December quarter (Q3FY25) results
 "Senores Pharmaceuticals races 17% on robust Q3; profit more than doubles")
Neuland Labs gets capex nod lift; stock up 5% even as broader indices sink
The company said it will spend Rs 254 crore for development and commercial production of Peptides for Generic Drug Substances (GDS) and Custom Manufacturing Solutions (CMS) business.
Indoco Remedies drops 4% on weak Q3 performance; revenue falls 11% YoY
Indoco Remedies share dropped after the company reported a weak set of numbers in the December quarter of financial year 2025 (Q3FY25)
 "Indoco Remedies drops 4% on weak Q3 performance; revenue falls 11% YoY")
Venus Remedies share price surges 12% on renewal of EU GMP certification
The rise in Venus Remedies share price came after the company announced the renewal of its European GMP certification by Infarmed, the National Authority of Medicines and Health Products in Portugal
 "Venus Remedies share price surges 12% on renewal of EU GMP certification")
